7
Views
0
CrossRef citations to date
0
Altmetric
Anti-Inflammatory, Anti-Allergic, Respiratory & GI Agents

Patent Update: Anti-Inflammatory Patents Highlights from the First Half of 1992

, &
Pages 1577-1592 | Published online: 02 Mar 2011

References to Primary Literature

  • Engle, A Roberts, J Burch, JA Rheumatoid Arthritis in Adults in the US 1960–62. Vital and Health Statistics Series II From the National Health Survey No: 17 National Center for Health Statistics Washington, D.C 1986.
  • Shearn, MA Arthritis and Musculoskeletal Disorders Current Medical Diagnosis and Treatment 1987 Krupp, MA, Schroeder, SA, Tierney, LM Appleton Lange USA 1987.
  • Lewis, AJ Glaser, KB Sturm, RJ Mölnar, KK Bansbach, CC Strategies for the development of new antiarthritic agents. Int. J. Immunopharmacol. 1992 14 497–504.
  • McMillan, RM Walker, ERH Designing therapeutically effective 5-lipoxygenase inhibitors. Trends Pharmacol. Sci. 1992 13 323–330.
  • Bell, RL Young, PR Albert, D Lanni, C Summers, JB Brooks, DW Rubin, P Carter, GW The Discovery and Development of Zileuton: An Orally Active 5-Lipoxygenase Inhibitor. Int. J. Immunopharmac. 1992 14 505–510.
  • Israel, E Drazen, J Pearlman, H Cohn, J Rubin, P A double-blind multicenter study of zileuton, a potent 5-lipoxygenase (5-LO) inhibitor versus placebo in the treatment of spontaneous asthma in adults. Journal of Allergy and Clinical Immunology 1992 89 236–236.
  • Crawley, GC Dowell, RI Edwards, PN Foster, SJ McMillan, RM Walker, ERH Waterson, D Methoxytetrahydropyrans: A New Series of Selective and Orally Potent 5-Lipoxygenase Inhibitors. J. Med. Chem. 1992 35 2600–2609.
  • Moilanen, E Alanko, I Azmawi, Z Vapaatalo, H CP-66248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene B4 and prostanoid synthesis in human polymorphponuclear leukocytes in vitro. Eicosanoids 1988 1 35.
  • Wilkens, H Wilkens, J Bosse, S Kempe, F Fritz, S Frolich, J Fabel, H Effects of an inhaled PAF-antagonist (WEB-2086) on allergen-induced early and late asthmatic responses and increased bronchial responsiveness to metacholine. Am. Rev. Respir. Dis. 1991 143 A812.
  • Bel, E De Smet, M Rossing, T Timmers, M Dijman, J Sterk, P The effect of a specific oral PAF antagonist, MK-287, on antigen-induced early and late asthmatic reactions in man. Am. Rev. Respir. Dis. 1991 143 A811.
  • Dermarkarian, R Israel, E Rosenberg, M Jansen, A Danzig, M Fourre, J Drazen, J The effect of Sch-37370, a dual platelet activating factor and histamine antagonist on the bronchoconstriction induced in asthmatics by cold, dry air isocapnic hyperventilation. Am. Rev. Respir. Dis. 1991 143 A812.
  • Kuitert, LM Hui, K Uthayarkumar, S Burke, W Newland, AC Uden, S Barnes, NC Effects of a platelet-activating factor (PAF) antagonist UK 74,505 on allergen-induced early and late response. Am. Rev. Respir. Dis. 1992 145 A292.
  • Takehara, S Mikashima, H Muramoto, Y Terasawa, M Setaguchi, M Tahara, T Pharmacological Action of Y-24180, a New Specific Antagonist of Platelet Activating Factor (PAF): II. Interactions with PAF and Benzodiazepine Receptors. Prostaglandins 1990 40 571.
  • Sehgal, SN Chang, JY Rapamycin: A New Immunosuppressive macrolide. SIM Industrial Microbiology NEWS 1992 230–233.
  • Morris, RE Rapamycins: Antifungal, antitumor, antiproliferative, and immunosuppressive macrolides. Transplantation Reviews 1992 6 39–87.
  • Sigal, NH Dumont, FJ Cyclosporin A, FK-506, and rapamycin: Pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 1992 10 519–560.
  • Siekerka, JJ Hung, SH Poe, M Lin, CS Sigal, NH A cytosolic binding protein for the immunosuppressant FK506 has peptidylprolyl isomerase activity but is distinct from cyclophilin. Nature 1989 341 755–757.
  • Harding, MW Galat, A Uehling, DE Schreiber, SL A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 1989 341 758–760.
  • Bierer, BE Somers, PK Wandless, TJ Burakoff, SJ Schreiber, SL Probing Immunosuppressant Action with a Nonnatural Immunophilin Ligand. Science 1990 250 556–559.
  • Schreiber, SL Crabtree, GR The mechanism of action of cyclosporin A and FK506. Immunology Today 1992 13 136–142.
  • Luly, JR Mechanism-based Immunosuppressants Annual Reports in Medicinal Chemistry Academic Press, Inc. San Diego 1991 211–220 Bristol JA.
  • Morris, RE Immunopharmacology of New Xenobiotic Immunosuppressive Molecules. Seminars in Nephtology 1992 12 304–314.
  • Bartlett, RR Mattar, T Weithmann, U Anagnostopoulos, H Popovic, S Schleyerbach, R Leflunomide (HWA 486): A novel immunorestoring drug Therapeutic Approa ches to Inflammatory Diseases Lewis, AJ, Doherty, NS, Ackerman, NR Elsevier Science Publishing Co New York 1989 215–217.
  • Makowka, L Cramer, DV Brequinar sodium: A new immunosuppressive drug for transplantation. Transplantation Science 1992 2 50–54.
  • Sircar, JC Gibertsen, RB Purine nucleoside phosphorylase (PNP) inhibitors: Potentially selective immunosuppressive agents. Drugs of the Future 1988 13 653–668.
  • Payan, DG Neuropeptides and inflammation: The role of substance P. Annu. Rev. Med. 1989 40 341.
  • Murthy, SN Depace, DM Shah, RS Podell, R Acute effect of substance P in immunologic vasculitis in the rat colon. Peptides 1991 12 1337.
  • Dinarello, CA Inflammatory cytokines: Interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases. Curr. Opin. Immunol. 1991 3 941–948.
  • Cerretti, DP Koslosky, CJ Mosley, B Nelson, N Van Ness, K Greenstreet, TA March, CJ Kronheim, SR Druck, T Cannizzaro, LA Huebner, K Black, RA Molecular Cloning of the Interleukin-1β Converting Enzyme. Science 1992 256 97–100.
  • Thornberry, NA Bull, HG Calaycay, JR Chapman, KT Howard, AD Kostura, MJ Miller, DK Molineauz, SM Weidner, JR Aunins, J Elliston, KO Ayala, JM Casano, FJ Chin, J Ding, GJF Egger, LA Gaffney, EP Limjuco, G Palyha, OC Raju, SM Rolando, AM Salley, JP Yamin, TT Lee, TD Shively, JE MacCross, M Mumford, RA Schmidt, JA Tocci, MJ A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 1992 356 768–774.
  • Pardi, R Inverardi, L Bender, JR Regulatory mechanisms in leukocyte adhesion: Flexible receptors for sophisticated travelers. Immunology Today 1992 13 224–230.
  • Shearer, BG Sullivan, JP Carter, JP Mathew, RM Waid, P Connor, JR Patch, FJ Burch, RM Substituted 2-(aminomethyl)piperidines: A novel class of selective protein kinase C inhibitors. J. Med. Chem. 1991 34 2928.
  • Madan, BR Al-Humayyad, MS Mobarok Ali, AA Action and interaction of nifedipine, indomethacin and aspirin in carrageenan-induced inflammation of the rat. Med. Sci. Res. 1989 17 191.
  • Al-Tuwauri, AS Mustafa, AA Verapamil enhances the inhibitory effect of diclofenac on the chemiluminescence of human polymorphonuclear leukocytes and carrageenan-induced rat's paw oedema. Int. J. Immunopharmac. 1992 14 83.

References to Patent Literature

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.